Literature DB >> 19195517

Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation.

Chung-Wah Siu1, Man-Hong Jim, Xuehua Zhang, Yap-Hang Chan, Vincent Pong, Jeanette Kwok, Annie W C Kung, Chu-Pak Lau, Hung-Fat Tse.   

Abstract

Hyperthyroidism-induced atrial fibrillation (AF) often spontaneously reverts to sinus rhythm after the return of euthyroid state, but a significant number of patients remain in persistent AF, which requires electrical cardioversion. The long-term outcome of hyperthyroidism-induced persistent AF after successful cardioversion remains unclear. The study group consisted of 58 patients with hyperthyroidism-induced persistent AF (mean age 57 +/- 2 years, 72% men) who had undergone successful electrical cardioversion. The AF recurrence rate was prospectively studied and compared with age- and gender-matched controls with persistent AF of nonthyroid origins. After a 24-month follow-up period, 34 patients (59%) had developed AF recurrence, significantly fewer than among controls (83%) (hazard ratio 0.64, 95% confidence interval 0.39 to 0.97, p = 0.04). Cox regression analysis showed that long AF duration was the only predictor of AF recurrence in patients with hyperthyroidism-induced persistent AF. In conclusion, hyperthyroidism-induced persistent AF carries a lower recurrence rate after conversion to sinus rhythm than non-hyperthyroidism-induced persistent AF, and early electrical cardioversion should be considered.

Entities:  

Mesh:

Year:  2008        PMID: 19195517     DOI: 10.1016/j.amjcard.2008.10.019

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  [Update hyperthyreoidism].

Authors:  L Möller; K Mann
Journal:  Internist (Berl)       Date:  2010-05       Impact factor: 0.743

Review 2.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marin; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Eur J Prev Cardiol       Date:  2016-11-04       Impact factor: 7.804

Review 3.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marín; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Europace       Date:  2017-02-01       Impact factor: 5.214

Review 4.  A review of factors associated with maintenance of sinus rhythm after elective electrical cardioversion for atrial fibrillation.

Authors:  Veronika Ecker; Charles Knoery; Gordon Rushworth; Ian Rudd; Astrid Ortner; David Begley; Stephen J Leslie
Journal:  Clin Cardiol       Date:  2018-06-07       Impact factor: 2.882

5.  Initial Precipitants and Recurrence of Atrial Fibrillation.

Authors:  Elizabeth Y Wang; Olivia L Hulme; Shaan Khurshid; Lu-Chen Weng; Seung Hoan Choi; Allan J Walkey; Jeffrey M Ashburner; David D McManus; Daniel E Singer; Steven J Atlas; Emelia J Benjamin; Patrick T Ellinor; Ludovic Trinquart; Steven A Lubitz
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-02-12

Review 6.  The bidirectional relationship of thyroid disease and atrial fibrillation: Established knowledge and future considerations.

Authors:  Alexandra Bekiaridou; Anastasios Kartas; Dimitrios V Moysidis; Andreas S Papazoglou; Amalia Baroutidou; Anastasios Papanastasiou; George Giannakoulas
Journal:  Rev Endocr Metab Disord       Date:  2022-02-02       Impact factor: 9.306

7.  Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease.

Authors:  Pak Hei Chan; Wen Hua Li; Jo Jo Hai; Hung Fat Tse; Chung Wah Siu
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

8.  Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study.

Authors:  Steven A Lubitz; Xiaoyan Yin; Michiel Rienstra; Renate B Schnabel; Allan J Walkey; Jared W Magnani; Faisal Rahman; David D McManus; Thomas M Tadros; Daniel Levy; Ramachandran S Vasan; Martin G Larson; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2015-03-13       Impact factor: 29.690

9.  New-onset atrial fibrillation is a predictor of subsequent hyperthyroidism: a nationwide cohort study.

Authors:  Christian Selmer; Morten Lock Hansen; Jonas Bjerring Olesen; Charlotte Mérie; Jesper Lindhardsen; Anne-Marie Schjerning Olsen; Jesper Clausager Madsen; Ulla Schmidt; Jens Faber; Peter Riis Hansen; Ole Dyg Pedersen; Christian Torp-Pedersen; Gunnar Hilmar Gislason
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

10.  Predictors of Atrial Fibrillation Recurrence in Hyperthyroid and Euthyroid Patients.

Authors:  Muhammet Gürdoğan; Hasan Ari; Erhan Tenekecioğlu; Selma Ari; Tahsin Bozat; Vedat Koca; Mehmet Melek
Journal:  Arq Bras Cardiol       Date:  2016-01-26       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.